(Q37867104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Enrico Proietti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Filippo Belardelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Imerio Capone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Franca Moretti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

487-498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

Fifty years of interferon research: aiming at a moving target

29 January 2020

cites work

1 reference

Cytokines as a link between innate and adaptive antitumor immunity.

21 January 2018

1 reference

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.

21 January 2018

1 reference

Adjuvant activity of type I interferons

21 January 2018

1 reference

Type I interferons as vaccine adjuvants against infectious diseases and cancer

21 January 2018

1 reference

Interferons as potential adjuvants in prophylactic vaccines

21 January 2018

1 reference

Regulation of adaptive immunity by the innate immune system

21 January 2018

1 reference

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

Type I interferon-mediated stimulation of T cells by CpG DNA

21 January 2018

1 reference

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses

21 January 2018

1 reference

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

21 January 2018

1 reference

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

21 January 2018

1 reference

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

21 January 2018

1 reference

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

21 January 2018

1 reference

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

21 January 2018

1 reference

IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment

21 January 2018

1 reference

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

21 January 2018

1 reference

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

21 January 2018

1 reference

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

21 January 2018

1 reference

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

The CD8+ dendritic cell subset

21 January 2018

1 reference

Innate recognition of viruses

21 January 2018

1 reference

Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists

21 January 2018

1 reference

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

21 January 2018

1 reference

Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells

21 January 2018

1 reference

Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen.

21 January 2018

1 reference

Regulatory T cells and autoimmunity

21 January 2018

1 reference

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment

21 January 2018

1 reference

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

Adjuvant activity of interferon alpha: mechanism(s) of action.

21 January 2018

1 reference

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

21 January 2018

1 reference

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice

21 January 2018

1 reference

Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults.

21 January 2018

1 reference

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

21 January 2018

1 reference

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

21 January 2018

1 reference

Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial

21 January 2018

1 reference

Disturbances of acquired immunity in hemodialysis patients

21 January 2018

1 reference

Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals

21 January 2018

1 reference

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

21 January 2018

1 reference

Redefining the role of interferon in the treatment of malignant diseases

21 January 2018

1 reference

Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications

21 January 2018

1 reference

Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.

21 January 2018

1 reference

IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity

21 January 2018

1 reference

The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines

21 January 2018

1 reference

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

21 January 2018

1 reference

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

21 January 2018

1 reference

The CD14+ CD16+ blood monocytes: their role in infection and inflammation

21 January 2018

1 reference

TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

21 January 2018

1 reference

Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma

21 January 2018

1 reference

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

21 January 2018

1 reference

Taking dendritic cells into medicine

21 January 2018

1 reference

Spontaneous regression of highly immunogenic Molluscum contagiosum virus (MCV)-induced skin lesions is associated with plasmacytoid dendritic cells and IFN-DC infiltration

21 January 2018

1 reference

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients

21 January 2018

1 reference

Desirable cell death during anticancer chemotherapy

21 January 2018

1 reference

Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals

21 January 2018

1 reference

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506646%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference